Linfomas
GLUN
Charles University in Prague
Praga, República ChecaPublications in collaboration with researchers from Charles University in Prague (4)
2023
2018
-
A phase ii multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy
Haematologica, Vol. 103, Núm. 8, pp. 1351-1358
-
Immunochemotherapy with obinutuzumab or rituximab for previously untreated follicular lymphoma in the GALLIUM study: Influence of chemotherapy on efficacy and safety
Journal of Clinical Oncology, Vol. 36, Núm. 23, pp. 2395-2404
-
Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial
The Lancet Oncology, Vol. 19, Núm. 11, pp. 1530-1542